January 1995
Volume 36, Issue 1
Free
Articles  |   January 1995
Perfluorinated organic liquid as an intraocular oxygen reservoir for the ischemic retina.
Author Affiliations
  • C A Wilson
    Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas 75235-9057.
  • B A Berkowitz
    Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas 75235-9057.
  • R Srebro
    Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas 75235-9057.
Investigative Ophthalmology & Visual Science January 1995, Vol.36, 131-141. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C A Wilson, B A Berkowitz, R Srebro; Perfluorinated organic liquid as an intraocular oxygen reservoir for the ischemic retina.. Invest. Ophthalmol. Vis. Sci. 1995;36(1):131-141.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

PURPOSE: Liquid perfluorocarbons are used as temporary vitreous substitutes in the surgical management of complicated retinal detachment. The purpose of this study was to determine if physiologic benefits could also be derived from the high oxygen solubility of perfluorochemicals relative to vitreous, especially during retinal ischemia. METHODS: The normal vitreous humor of the rabbit eye was replaced with either perfluorotributylamine (FTBA) or balanced salt solution (BSS). Retinal ischemia was then induced by increasing the intraocular pressure above the peak systolic blood pressure for intervals of 10, 30, or 90 minutes. RESULTS: Over a 10- or 30-minute period of ischemia, during which electroretinographic (ERG) responses were recorded, FTBA-filled eyes and BSS-filled eyes showed decreases in the a- and b-wave amplitudes. However, wave amplitudes were significantly greater in FTBA-filled eyes at most times examined (P < .05). ERG responses were maintained throughout a 30-minute ischemic interval in oxygenated FTBA-filled eyes, but not in oxygenated BSS- or deoxygenated FTBA-filled eyes. When examined 1 day after a 90-minute interval of ischemia, oxygenated FTBA-filled eyes maintained 45% and 57% of the preischemic ERG a- and b-wave amplitudes, respectively, compared to a 5% and 3% retention of wave amplitudes in oxygenated BSS-filled eyes. On light microscopic examination of these eyes, FTBA-exposed retinas showed less ischemic damage than BSS-exposed retinas. CONCLUSIONS: When used as a vitreous substitute, FTBA exerts a neuroprotective effect on the ischemic retina that appears to relate to an increased retinal oxygen supply compared to BSS.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×